The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey

被引:58
作者
Molteni, Mauro [1 ]
Friz, Hernan Polo [1 ]
Primitz, Laura [1 ]
Marano, Giuseppe
Boracchi, Patrizia
Cimminiello, Claudio [1 ]
机构
[1] Vimercate Hosp, Div Internal Med, Dept Med, I-20871 Vimercate, Italy
来源
EUROPACE | 2014年 / 16卷 / 12期
关键词
Atrial fibrillation; Valvular; Non-valvular; Anti-thrombotic therapy; Stroke; Survey; 2010 ESC GUIDELINES; EUROPEAN-SOCIETY; MEMBER COUNTRIES; WARFARIN; MANAGEMENT; RIVAROXABAN; DABIGATRAN; APIXABAN; STROKE;
D O I
10.1093/europace/euu178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To assess different aspects of the definition of valvular/non-valvular atrial fibrillation (AF) used in clinical practice by physicians who usually treat this condition. Methods and results We prospectively conducted a web-based survey including cardiologists and internists who attended continuing medical education courses on cardiovascular medicine. A questionnaire was drawn up, containing 17 questions clustered into five main topics: (A) known rheumatic aetiology; (B) site/type of valve involvement; (C) prosthetic heart valve; (D) haemodynamic relevance; (E) miscellaneous. The overall response rate was 22.4%(21.1% for cardiologists and 24% for internists). Coexistence of both medical history of rheumatic disease and clinical signs of valvular involvement were considered as essential prerequisites for the diagnosis of rheumatic AF by half of the respondents, and one-third assumed that lone aortic valve disease was sufficient for AF to be defined as valvular. A similar proportion of respondents considered that in the presence of mitral regurgitation, AF had to be defined as valvular. The majority of responding physicians considered the degree of valvular defect of lesser importance for the definition of valvular or non-valvular origin of AF. Conclusion We found important heterogeneity and uncertainties in the answers given by physicians who usually treat patients with AF, as evidence of the lack of precise and unique definitions of the origin of AF (valvular/non-valvular). It is urgent to issue clear widely accepted definitions of the origin of AF, which should improve clinical practice and research.
引用
收藏
页码:1720 / 1725
页数:6
相关论文
共 21 条
[1]  
[Anonymous], 2013, EPI PACKAGE STAT ANA
[2]  
Avezum A, 2013, EUR HEART J, V34, P809
[3]   OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND SIGNIFICANT VALVULAR LESIONS: COMPARISON OF THE EFFECTS OF RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL [J].
Breithardt, Guenter ;
Berkowitz, Scott ;
Baumgartner, Helmut ;
Hellkamp, Anne ;
Piccini, Jonathan ;
Stevens, Susanna ;
Lokhnygina, Yuliya ;
Patel, Manesh ;
Halperin, Jonathan ;
Singer, Daniel ;
Hankey, Graeme ;
Hacke, Werner ;
Becker, Richard ;
Nessel, Christopher ;
Mahaffey, Kenneth ;
Califf, Robert ;
Fox, Keith .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) :E339-E339
[4]  
Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/eurheartj/ehs253, 10.1093/europace/eus305]
[5]  
Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]
[6]   Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].
Connolly, Stuart J. ;
Ezekowitz, Michael D. ;
Yusuf, Salim ;
Eikelboom, John ;
Oldgren, Jonas ;
Parekh, Amit ;
Pogue, Janice ;
Reilly, Paul A. ;
Themeles, Ellison ;
Varrone, Jeanne ;
Wang, Susan ;
Alings, Marco ;
Xavier, Denis ;
Zhu, Jun ;
Diaz, Rafael ;
Lewis, Basil S. ;
Darius, Harald ;
Diener, Hans-Christoph ;
Joyner, Campbell D. ;
Wallentin, Lars .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151
[7]   Dabigatran versus Warfarin in Patients with Mechanical Heart Valves [J].
Eikelboom, John W. ;
Connolly, Stuart J. ;
Brueckmann, Martina ;
Granger, Christopher B. ;
Kappetein, Arie P. ;
Mack, Michael J. ;
Blatchford, Jon ;
Devenny, Kevin ;
Friedman, Jeffrey ;
Guiver, Kelly ;
Harper, Ruth ;
Khder, Yasser ;
Lobmeyer, Maximilian T. ;
Maas, Hugo ;
Voigt, Jens-Uwe ;
Simoons, Maarten L. ;
Van de Werf, Frans .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (13) :1206-1214
[8]   ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation:: full text [J].
Fuster, Valentin ;
Ryden, Lars E. ;
Cannom, David S. ;
Crijns, Harry J. ;
Curtis, Anne B. ;
Ellenbogen, Kenneth A. ;
Halperin, Jonathan L. ;
Le Heuzey, Jean-Yves ;
Kay, G. Neal ;
Lowe, James E. ;
Olsson, S. Bertil ;
Prystowsky, Eric N. ;
Tamargo, Juan Luis ;
Wann, Samuel .
EUROPACE, 2006, 8 (09) :651-745
[9]   Selecting patients with atrial fibrillation for anticoagulation - Stroke risk stratification in patients taking aspirin [J].
Gage, BF ;
van Walraven, C ;
Pearce, L ;
Hart, RG ;
Koudstaal, PJ ;
Petersen, P .
CIRCULATION, 2004, 110 (16) :2287-2292
[10]   Edoxaban versus Warfarin in Patients with Atrial Fibrillation [J].
Giugliano, Robert P. ;
Ruff, Christian T. ;
Braunwald, Eugene ;
Murphy, Sabina A. ;
Wiviott, Stephen D. ;
Halperin, Jonathan L. ;
Waldo, Albert L. ;
Ezekowitz, Michael D. ;
Weitz, Jeffrey I. ;
Spinar, Jindrich ;
Ruzyllo, Witold ;
Ruda, Mikhail ;
Koretsune, Yukihiro ;
Betcher, Joshua ;
Shi, Minggao ;
Grip, Laura T. ;
Patel, Shirali P. ;
Patel, Indravadan ;
Hanyok, James J. ;
Mercuri, Michele ;
Vogelmann, O. ;
Gonzalez, C. ;
Ahuad Guerrero, R. ;
Rodriguez, M. ;
Albisu, J. ;
Rosales, E. ;
Allall, O. ;
Reguero, M. ;
Alvarez, C. ;
Garcia, M. ;
Ameriso, S. ;
Ameriso, P. ;
Amuchastegui, M. ;
Caceres, M. ;
Beloscar, J. ;
Petrucci, J. ;
Berli, M. ;
Budassi, N. ;
Valle, M. ;
Bustamante Labarta, G. ;
Saravia, M. ;
Caccavo, A. ;
Fracaro, V. ;
Cartasegna, L. ;
Novas, V. ;
Caruso, O. ;
Saa Zarandon, R. ;
Colombo, H. ;
Morandini, M. ;
Cuello, J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22) :2093-2104